Evidence map›Paper›PMID 41000947›Full record

ArticlebioRxiv : the preprint server for biology2025

Quantifying HLA transcripts by genotype in chimeric mixtures at single-cell resolution.

Sami B Kanaan, Jason G Underwood, Rula Green Gladden, Everett Fan, Shruti S Bhise, Monica S Thakar, Carla A Jaeger-Ruckstuhl, Jeffrey Stevens, Ashley N Gray, Stanley R Riddell and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sami B KanaanTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-4608-0953
Jason G UnderwoodPacific Biosciences of California, Menlo Park, CA, USA.
Rula Green GladdenTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Everett FanTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Shruti S BhiseTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Monica S ThakarDepartment of Pediatrics, University of Washington, Seattle, WA, USA.
Carla A Jaeger-RuckstuhlTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Jeffrey StevensSeattle Children's Research Institute, Seattle, WA, USA.
Ashley N GrayCancer and Blood Disease Institute, Pediatric Transplantation and Cellular Therapy, Children's Hospital Los Angeles (CHLA), Los Angeles, CA, USA.
Stanley R RiddellTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Marie BleakleyTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Soheil MeshinchiTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Scott N FurlanTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Funding

A compass for those with relapsed leukemia after transplantR01CA289886 · NCI · FRED HUTCHINSON CANCER CENTER · PI Scott Nicholas Furlan · 2024 to 2026
$3.5M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NCI NIH HHS R01 CA289886NIH HHS S10 OD020069NIH HHS S10 OD028685
6 · The paper itself

Abstract

Gene products from the highly variable major histocompatibility locus, including HLA, are essential for self-recognition and immune surveillance of malignancy. Following allogeneic hematopoietic cell transplantation (alloHCT), genetic and epigenetic alterations in HLA can drive disease recurrence, making precise HLA assessment critical for determining future therapy. However, current methods lack the sensitivity to quantify HLA transcripts at the single-cell level, limiting their clinical utility. We introduce

Identifiers

PMID41000947
PMCPMC12458259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.